Stein Kvaløy
Impact in
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 60
- Oncology 34
- CAR-T cell therapy research 8
- Cancer survivorship and care 7
- Neutropenia and Cancer Infections 6
- Co-authors
- Harald Holte (46 shared papers)Ole Nome (11 shared papers)Gunnar Kvalheim (16 shared papers)A. Foss Abrahamsen (9 shared papers)Hans Hagberg (4 shared papers)Matthew Robert Sydes (3 shared papers)Knut Lote (4 shared papers)Harry C. Schouten (2 shared papers)
- Journals
- Bone Marrow Transplantation (9 papers)Annals of Oncology (9 papers)Acta Oncologica (9 papers)Blood (6 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- NorwayGermanyUnited States
In The Last Decade
Stein Kvaløy
103 papers receiving 13.7k citations
Stein Kvaløy's Hit Papers
Peers
Comparison fields: 5 of 140
- Pathology and Forensic Medicine 8.8k
- Genetics 3.3k
- Oncology 5.5k
- Neurology 2.0k
- Immunology 2.1k
Countries citing papers authored by Stein Kvaløy
This map shows the geographic impact of Stein Kvaløy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stein Kvaløy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stein Kvaløy more than expected).
Fields of papers citing papers by Stein Kvaløy
This network shows the impact of papers produced by Stein Kvaløy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stein Kvaløy. The network helps show where Stein Kvaløy may publish in the future.
Co-authors
The 25 scholars most cited alongside Stein Kvaløy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma Hit paper breakdown → | 2002 | 3164 |
| 2 | CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Hit paper breakdown → | 2006 | 1705 |
| 3 | Stromal Gene Signatures in Large-B-Cell Lymphomas Hit paper breakdown → | 2008 | 1464 |
| 4 | Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells Hit paper breakdown → | 2004 | 1136 |
| 5 | Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma Hit paper breakdown → | 2003 | 882 |
| 6 | The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma Hit paper breakdown → | 2003 | 736 |
| 7 | Molecular Diagnosis of Burkitt's Lymphoma Hit paper breakdown → | 2006 | 690 |
| 8 | CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group Hit paper breakdown → | 2011 | 653 |
| 9 | 2003 | 383 | |
| 10 | 1997 | 374 | |
| 11 | 2002 | 213 | |
| 12 | 2007 | 199 | |
| 13 | 2008 | 181 | |
| 14 | 1993 | 140 | |
| 15 | 2001 | 112 | |
| 16 | 2010 | 110 | |
| 17 | 2002 | 98 | |
| 18 | 2001 | 86 | |
| 19 | 1999 | 82 | |
| 20 | Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. | 2003 | 80 |
About Stein Kvaløy
Stein Kvaløy is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Neurology, having authored 104 papers that have together received 14.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (60 papers), Immune Cell Function and Interaction (11 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (10 papers), CAR-T cell therapy research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer survivorship and care (7 papers) and Neutropenia and Cancer Infections (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (8.8k citations), Genetics (3.3k citations), Oncology (5.5k citations), Neurology (2.0k citations) and Immunology (2.1k citations). Stein Kvaløy has collaborated with scholars based in Norway, Germany and United States. Frequent co-authors include Harald Holte, Ole Nome, Gunnar Kvalheim, A. Foss Abrahamsen, Hans Hagberg, Matthew Robert Sydes, Knut Lote, Harry C. Schouten, Wendi Qian and Eva K. Cavallin-Ståhl. Their work appears in journals such as Bone Marrow Transplantation, Annals of Oncology, Acta Oncologica, Blood and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.